Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2150922011 | Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2158715013 | Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Buprenorphine hydrochloride + naloxone hydrochloride | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Naloxone hydrochloride | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Opioid receptor partial agonist | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Chelating agent | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Buprenorphine hydrochloride | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Buprenorphine (substance) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Product containing buprenorphine and naloxone (medicinal product) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Has manufactured dose form | Sublingual tablet | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Product containing naloxone in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Product containing buprenorphine in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Product containing buprenorphine and naloxone in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | Product manufactured as oromucosal dose form (product) | false | Inferred relationship | Some | ||
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR